Vapotherm Rises on Internet of Medical Things Solution Partnership

Global medical technology company, Vapotherm (OTCQX: VAPO) topped the PRISM Emerging Medical Devices Index on Wednesday, rising +15.94% in intraday trading. The company’s share price has performed strongly over the past three months after it announced a development and commercialization partnership with Onymos to create an end-to-end Internet of Medical Things solution (IoMT), in March.

Vapotherm’s proprietary high-velocity therapy products treat patients in respiratory distress. The partnership will help the company create a unique respiratory digital platform to meet its data visualization and device management goals for the Vapotherm HVT® 2.0 system in the acute care space as well as for future products in the home.

“We believe that by adopting Onymos’ suite of IoT features into these products it will help medical teams make informed decisions quickly to help treat their patients and improve outcomes at a lower cost. This is huge for understaffed hospitals especially. It’s an honor to help our customers and to partner with Onymos to make our connected cloud solutions a reality – one that continues to enhance and adjust according to physician feedback and needs,” said Vapotherm’s Chief Technology Officer, Brian Lawrence.

Through the Onymos Features-as-a-Service platform, Vapotherm accesses Onymos’ suite of Internet of Things (IoT) features — including Onymos Edge, Onymos Access, and Onymos DataStore — to build a secure end-to-end solution to connect the HVT 2.0 fleet with the cloud. The solution is currently undergoing beta testing with select hospitals.

About Vapotherm

Vapotherm, Inc. (OTCQX: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 4.2 million patients have been treated with the use of Vapotherm high-velocity therapy® systems. For more information, visit

Share This Article


About the Author

Vapotherm Rises on Internet of Medical Things Solution Partnership

Catie Corcoran

Biotech Editor